Soleus Private Equity Fund III L.P. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Private Equity Fund III L.P. | 1,343,665 9.000% |
1,343,665 (New Position) |
Filing |